| Literature DB >> 22215954 |
Aparecida Maria Fontes1, Simone Kashima, Ricardo Bonfim-Silva, Rochele Azevedo, Kuruvilla Joseph Abraham, Sérgio Roberto Lopes Albuquerque, José Orlando Bordin, Dante Mário Langhi Júnior, Dimas Tadeu Covas.
Abstract
Complement receptor 1 (CR1) gene polymorphisms that are associated with Knops blood group antigens may influence the binding of Plasmodium parasites to erythrocytes, thereby affecting susceptibility to malaria. The aim of this study was to evaluate the genotype and allele and haplotype frequencies of single-nucleotide polymorphisms (SNPs) of Knops blood group antigens and examine their association with susceptibility to malaria in an endemic area of Brazil. One hundred and twenty-six individuals from the Brazilian Amazon were studied. The CR1-genomic fragment was amplified by PCR and six SNPs and haplotypes were identified after DNA sequence analysis. Allele and haplotype frequencies revealed that the Kn(b) allele and H8 haplotype were possibly associated with susceptibility to Plasmodium falciparum. The odds ratios were reasonably high, suggesting a potentially important association between two Knops blood antigens (Kn(b) and KAM(+)) that confer susceptibility to P. falciparum in individuals from the Brazilian Amazon.Entities:
Keywords: Brazilian Amazon population; CR1 haplotypes; Knops blood group polymorphism; malaria
Year: 2011 PMID: 22215954 PMCID: PMC3229105 DOI: 10.1590/S1415-47572011005000051
Source DB: PubMed Journal: Genet Mol Biol ISSN: 1415-4757 Impact factor: 1.771
Haplotyes previously defined by six SNPs in the CR1 gene.
| Identifier | Haplotype | |||||
|---|---|---|---|---|---|---|
| N1540S | ||||||
| H1 | A | G | A | A | T | A |
| H2 | A | G | A | A | T | G |
| H3 | A | G | A | G | T | G |
| H4 | A | G | G | A | T | G |
| H5 | A | G | G | G | T | G |
| H6 | A | G | G | G | T | A |
| H7 | A | G | A | G | T | A |
| H8 | A | A | A | A | T | G |
| H9 | G | G | A | A | T | G |
| H10 | G | G | A | A | T | A |
| H11 | A | A | A | A | T | A |
| H12 | A | G | A | A | A | G |
Genotype frequencies of six SNPs in the CR1 gene in control subjects and three groups of infected subjects (P. falciparum, P. vivax and P.falciparum + P. vivax).
| Controls (n = 27) | p | p | p | |||||
|---|---|---|---|---|---|---|---|---|
| CR1- | A/A | 18 (66.6%) | 21 (84%) | 28 (82.3%) | 27 (81.8%) | |||
| N1540S | A/G | 7 (25%) | 4 (16%) | 6 (17.7%) | 6 (18.2%) | |||
| G/G | 2 (7.4%) | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| - | - | - | ||||||
| CR1- | G/G | 26 (93.3%) | 18 (72%) | 28 (82.3%) | 26 (78.8%) | |||
| V1561M | G/A | 1 (3.7%) | 7 (28%) | 6 (17.7%) | 7 (21.2%) | |||
| A/A | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| 0.0216 | 0.1207 | 0.063 | ||||||
| CR1- | A/A | 25 (92.6%) | 21 (84%) | 31 (91.2%) | 31 (93.9%) | |||
| K1590E | A/G | 2 (7.4%) | 4 (16%) | 2 (5.9%) | 2 (6.1%) | |||
| G/G | 0 (0%) | 0 (0%) | 1 (2.9%) | 0 (0%) | ||||
| - | - | - | ||||||
| CR1- | A/A | 20 (74.1%) | 17 (68%) | 30 (88.2%) | 23 (69.7%) | |||
| R1601G | A/G | 7 (25.9%) | 8 (32%) | 3 (8.8%) | 9 (27.3%) | |||
| G/G | 0 (0%) | 0 (0%) | 1 (3%) | 1 (3%) | ||||
| 0.630 | 0.319 | 0.563 | ||||||
| CR1- | T/T | 27 (100%) | 25 (100%) | 34 (100%) | 33 (100%) | |||
| S1610T | T/A | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | |||
| A/A | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| __ | __ | __ | ||||||
| CR1- | A/A | 10 (37%) | 5 (20%) | 12 (35.3%) | 12 (36.4%) | |||
| I1615V | A/G | 11 (40.7%) | 15 (60%) | 14 (41.2%) | 12 (36.4%) | |||
| G/G | 6 (22.3%) | 5 (20%) | 8 (23.5%) | 9 (27.2%) | ||||
| 0.448 | 0.876 | 0.776 | ||||||
Genotype frequencies of six SNPs in the CR1 gene in control subjects and all Plasmodium-infected groups combined.
| Controls (n = 27) | Infected cases (n = 92) | p | ||
|---|---|---|---|---|
| A/A | 18 (66.7%) | 76 (82.6%) | ||
| N1540S | A/G | 7 (25.9%) | 16 (17.4%) | |
| G/G | 2 (7.4%) | 0 (0%) | ||
| - | ||||
| CR1- | G/G | 26 (96.3%) | 72 (78.3%) | |
| V1561M | G/A | 1 (3.7%) | 20 (21.7%) | |
| A/A | 0 (0%) | 0 (0%) | ||
| 0.0415 | ||||
| CR1- | A/A | 25 (92.6%) | 83 (90.2%) | |
| K1590E | A/G | 2 (7.4%) | 8 (8.7%) | |
| G/G | 0 (0%) | 1 (1.1%) | ||
| - | ||||
| CR1- | A/A | 20 (74.1%) | 70 (76.1%) | |
| R1601G | A/G | 7 (25.9%) | 20 (21.7%) | |
| G/G | 0 (0%) | 2 (2.2%) | ||
| - | ||||
| CR1- | T/T | 27 (100%) | 92 (100%) | |
| S1610T | T/A | 0 (0%) | 0 (0%) | |
| A/A | 0 (0%) | 0 (0%) | ||
| - | ||||
| CR1- | A/A | 10 (37.0%) | 29 (31.5%) | |
| I1615V | A/G | 11 (40.7%) | 41 (44.5%) | |
| G/G | 6 (22.3%) | 22 (24.0%) | ||
| - | ||||
Allele frequencies in the Knops blood system in control subjects and in three groups of infected individuals (P. falciparum, P. vivax and P. falciparum + P. vivax).
| Controls (n = 27) | p | p | p | |||||
|---|---|---|---|---|---|---|---|---|
| CR1- | A | 0.80 | 0.92 | 0.91 | 0.91 | |||
| N1540S | G | 0.20 | 0.08 | 0.09 | 0.09 | |||
| 0.096 | 0.112 | 0.113 | ||||||
| CR1- | Kna | 0.98 | 0.86 | 0.91 | 0.89 | |||
| Knb | 0.02 | 0.14 | 0.09 | 0.11 | ||||
| 0.027 | 0.132 | 0.072 | ||||||
| CR1- | McCa | 0.96 | 0.92 | 0.94 | 0.97 | |||
| McCb | 0.04 | 0.08 | 0.06 | 0.03 | ||||
| 0.424 | 0.692 | 1.000 | ||||||
| CR1-4828 A > G | Sl1 | 0.87 | 0.84 | 0.93 | 0.83 | |||
| Sl2 | 0.13 | 0.16 | 0.07 | 0.17 | ||||
| 0.782 | 0.366 | 0.617 | ||||||
| CR1- | Sl4 | 1.00 | 1.00 | 1.00 | 1.00 | |||
| Sl5 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| __ | __ | __ | ||||||
| CR1- | KAM− | 0.57 | 0.50 | 0.56 | 0.54 | |||
| KAM+ | 0.43 | 0.50 | 0.44 | 0.46 | ||||
| 0.555 | 1.000 | 0.854 | ||||||
Haplotype frequencies of six SNPs in the CR1 gene in control subjects and in three groups of infected individuals (P. falciparum, P. vivax and P. falciparum + P. vivax).
| Group | H1 | H2 | H3 | H4 | H5 | H6 | H7 | H8 | H9 | H10 | H11 | H12 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Controls (n = 27) | 0.37 | 0.28 | 0.9 | _ | 0.04 | _ | _ | 0.02 | _ | 0.20 | _ | _ |
| 0.42 | 0.20 | 0.08 | _ | 0.08 | _ | _ | 0.14 | _ | 0.08 | _ | _ | |
| 0.47 | 0.28 | 0.01 | _ | 0.06 | _ | _ | 0.09 | _ | 0.09 | _ | _ | |
| 0.45 | 0.18 | 0.14 | _ | 0.03 | _ | _ | 0.11 | _ | 0.09 | _ | _ |